Related Experiment Video
Updated: May 30, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
ULK1 inhibits the kinase activity of mTORC1 and cell proliferation
Chang Hwa Jung1, Minchul Seo, Neil Michael Otto
1Department of Biochemistry, Molecular Biology and Biophysics; University of Minnesota, Minneapolis, MN, USA.
Abstract:
ULK1 (Unc51-like kinase, hATG1) is a Ser/Thr kinase that plays a key role in inducing autophagy in response to starvation. ULK1 is phosphorylated and negatively regulated by the mammalian target of rapamycin complex 1 (mTORC1). Previous studies have shown that ULK1 is not only a downstream effector of mTORC1 but also a negative regulator of mTORC1 signaling. ( 1-3) Here, we investigated how ULK1 regulates mTORC1 signaling, and found that ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. Deficiency or knockdown of ULK1 or its homolog ULK2 enhanced mTORC1 signaling, cell proliferation rates and accumulation of cell mass, whereas overexpression of ULK1 had the opposite effect. Knockdown of Atg13, the binding partner of ULK1 and ULK2, mimicked the effects of ULK1 or ULK2 deficiency or knockdown. Both insulin and leucine stimulated mTORC1 signaling to a greater extent when ULK1 or ULK2 was deficient or knocked down. In contrast, Atg5 deficiency did not have a significant effect on mTORC1 signaling and cell proliferation. The stimulatory effect of ULK1 knockdown on mTORC1 signaling occurred even in the absence of tuberous sclerosis complex 2 (TSC2), the negative regulator of mTORC1 signaling. In addition, ULK1 was found to bind raptor, induce its phosphorylation, and inhibit the kinase activity of mTORC1. These results demonstrate that ULK1 negatively regulates the kinase activity of mTORC1 and cell proliferation in a manner independent of Atg5 and TSC2. The inhibition of mTORC1 by ULK1 may be important to coordinately regulate cell growth and autophagy with optimized utilization of cellular energy.
Insights
Unc51-like kinase 1 (ULK1) inhibits mTORC1 signaling and cell proliferation. ULK1 deficiency enhances mTORC1 activity and cell growth, independent of Atg5 and TSC2, suggesting a key role in energy utilization.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- Unc51-like kinase 1 (ULK1) is a key regulator of autophagy induction.
- ULK1 is known to be negatively regulated by the mammalian target of rapamycin complex 1 (mTORC1).
- Previous research suggests ULK1 acts as both a downstream target and a negative regulator of mTORC1 signaling.
Purpose of the Study:
- To investigate the mechanism by which ULK1 regulates mTORC1 signaling.
- To determine the role of ULK1 in controlling cell proliferation and mTORC1 activity.
Main Methods:
- Investigated ULK1 and ULK2 deficiency/knockdown effects on mTORC1 signaling and cell proliferation.
- Examined the impact of Atg13 and Atg5 deficiency on mTORC1 signaling.
- Assessed ULK1's interaction with raptor and its effect on mTORC1 kinase activity.
- Studied ULK1's regulatory role in the presence and absence of TSC2.
Main Results:
- ULK1 deficiency or knockdown enhanced mTORC1 signaling, cell proliferation, and cell mass accumulation.
- Overexpression of ULK1 reduced mTORC1 signaling and cell proliferation.
- Knockdown of Atg13 mimicked the effects of ULK1/ULK2 deficiency.
- ULK1 directly binds raptor, phosphorylates it, and inhibits mTORC1 kinase activity, independent of Atg5 and TSC2.
Conclusions:
- ULK1 acts as a negative regulator of mTORC1 kinase activity and cell proliferation.
- This regulation occurs independently of Atg5 and TSC2.
- ULK1's inhibition of mTORC1 is crucial for coordinating cell growth and autophagy for optimal energy use.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation

